Dr. Jeffrey Greenfield, Co-Founder of the Children’s Brain Tumor Project, has accepted an invitation to become a standing member of the Weill Cornell Medicine Englander Institute for Precision Medicine. Dr. Greenfield’s formal affiliation with the Institute is in recognition of his work in genomic sequencing of pediatric brain tumors and his ongoing research collaboration with the Institute.
The St. Baldrick’s Foundation, the largest private funder of childhood cancer research grants, has just announced its newest round of grants, and Weill Cornell’s Children’s Brain Tumor Project is proud to be a recipient. St. Baldrick’s has committed to grant more than $2 million to support the next generation of St. Baldrick’s Fellows and Summer Fellows at 27 institutions across the U.S.
The Children’s Brain Tumor Project is a leader in leveraging precision medicine to help inform customized treatment protocols for children with brain tumors. As a result, Dr. Jeffrey Greenfield’s lab team was invited to present at the 2nd Pediatric Precision Oncology Conference.
One of the unique things about the Children’s Brain Tumor Project laboratory is how personally we all take this work. Nothing shows that quite like the hallway of our lab, which is lined with photos of children whose lives were claimed by these terrible, incurable tumors. We see these faces every day, to remind us that we are not just scientists working on cells. We are working for children, and for the families who love them, in a daily race to find new treatments. Every picture on our wall tells us the story not just of a child but of that child’s devastated family, and as we walk past each one we remember why we do what we do: to create hope. Read more
Our families continue to astound us with their loyalty and generosity. From California to New York to Florida, the events kept happening and the funding kept coming. We are so tremendously grateful to all of you! Read more
Building on the success of last year’s “Summer Sprint,” the Children’s Brain Tumor Project has initiated several new projects that take advantage of summer grants as well as the additional resources we now have available through Dr. Dahmane’s laboratory. Read more
These are exciting times in pediatric neuro-oncology research, and nowhere is that excitement felt more than right here in the CBTP labs. We have recently doubled in size, thanks to the generous support of our families and friends. Where once our two teams worked side by side, taking parallel paths toward our common goal, now we are four. And we couldn’t be happier about that. Read more
It is always a heartwarming and emotional experience to meet with other families who have lost a child to brain cancer. I had the true pleasure to connect with a group of parents, all of whom had lost a child to the rare brain cancer gliomatosis cerebri, at the Second International Gliomatosis Cerebri Conference, which was recently held at the National Institutes of Health.
The powerful emotions we felt were highlighted by the fact that we were there with a number of the brightest neurosurgeons, neuro-oncologists, researchers, and others who were fully committed to learning more about this cancer, sharing research, and finding effective treatments so no other families would have to go through such a loss. Read more
Dr. Michael Kaplitt, our Vice Chair for Research, made news this summer when he became the first in New York to use Magnetic Resonance-guided Focused Ultrasound (MRgFUS) to treat patients with essential tremor, just a week after the technology received FDA approval. The completely non-invasive technique uses 1,000 low-energy ultrasound waves focused on a precise spot in the brain, each individual wave sparing healthy tissue while the combined energy destroys its target. Read more